Clinical Trial Update: Buspirone and Melatonin for Depression Following Traumatic Brain Injury [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating buspirone and melatonin for Depression following traumatic brain injury; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Traumatic Brain Injury

Drugs mentioned

• Buspirone (buspirone)
• Melatonin (melatonin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depression, Brain Injuries, Traumatic | Phase 4 | Status: RECRUITING